Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. 4 Open-market sale Chief Operating Officer sold 2,191 shares at $151.21 ($331,301)
  2. 4 Open-market sale Director sold 20,000 shares at an average $154.61 ($3,092,278)
  3. 4 Planned sale Director sold 25,000 shares at an average $156.88 ($3,921,940)
  4. 4 Shares withheld for taxes Chief Executive Officer gave up 1,248 shares (to pay taxes)
  5. 4 Shares withheld for taxes CFO gave up 412 shares (to pay taxes)
  6. 4 Open-market sale Director sold 29,111 shares at an average $120.52 ($3,508,389)
  7. 4 Grant or award CHIEF ACCOUNTING OFFICER acquired 4,142 shares (grant or award)
  8. 4 Shares withheld for taxes Chief Executive Officer gave up 2,506 shares (to pay taxes)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market buy Director bought 1,800 shares at $112.13 ($201,830)
  11. 4 Grant or award Director acquired 973 shares (grant or award)
  12. 4 Grant or award Director acquired 973 shares (grant or award)
  13. 4 Grant or award Director acquired 973 shares (grant or award)
  14. 4 Grant or award Director acquired 973 shares (grant or award)
  15. 4 Grant or award Director acquired 973 shares (grant or award)
  16. 4 Grant or award Director acquired 973 shares (grant or award)
  17. 4 Grant or award Director acquired 973 shares (grant or award)
  18. 4 Grant or award Director acquired 973 shares (grant or award)
  19. 4 Planned sale Director sold 26,447 shares at an average $123.71 ($3,271,688)
  20. 4 Shares withheld for taxes Chief Operating Officer gave up 454 shares (to pay taxes)

Page 3 of 34 · 669 filings